The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARCELLX INC COMMON STOCK 03940C100   5,858,938 189,120 SH   SOLE   189,120 0 0
AVEO PHARMACEUTICALS INC COM NEW 053588307   3,671,810 245,606 SH   SOLE   245,606 0 0
DAY ONE BIOPHARMACEUTICALS I COM 23954D109   21,427,163 995,686 SH   SOLE   995,686 0 0
FLYWIRE CORPORATION COM VTG 302492103   1,149,111 46,960 SH   SOLE   46,960 0 0
TRANSDIGM GROUP INC COM 893641100   2,852,315 4,530 SH   SOLE   4,530 0 0
TOAST INC CL A 888787108   21,074,744 1,168,871 SH   SOLE   1,168,871 0 0